ICD-10 · PDGM grouping

E20-E35 — Disorders of other endocrine glands

Every ICD-10-CM code in this range and the PDGM clinical group CMS assigns to it, read from the CMS grouper crosswalk v07.1.26.

OASIS-E2 v1.00.0 · ingested 2026-04-26

Codes in range

99

No clinical group

21

A period cannot be grouped from these.

Barred as primary

0

CMS rejects these in the primary position.

Where these codes group

64 of the 99 codes in E20-E35 group to MMTA - Endocrine, but the range is not uniform — it spreads across 2 clinical groups. A further 21 are assigned no clinical group at all, which means a 30-day period cannot be grouped from them.

Every code in E20-E35

Descriptions are CMS’s own, abbreviated as CMS abbreviates them.

CodeDescriptionClinical groupPrimary position
E200Idiopathic hypoparathyroidismIAccepted
E201PseudohypoparathyroidismIAccepted
E20810Autosomal dominant hypocalcemiaIAccepted
E20811Secondary hypoparathyroidism in diseases classd elswhrNoneCannot group
E20812Autoimmune hypoparathyroidismIAccepted
E20818Oth hypoparathyroidism due to impaired PTH secretionIAccepted
E20819Hypoparathyroidism due to impaired PTH secretion, unspIAccepted
E2089Other specified hypoparathyroidismIAccepted
E209Hypoparathyroidism, unspecifiedIAccepted
E210Primary hyperparathyroidismIAccepted
E211Secondary hyperparathyroidism, not elsewhere classifiedIAccepted
E212Other hyperparathyroidismIAccepted
E213Hyperparathyroidism, unspecifiedIAccepted
E214Other specified disorders of parathyroid glandIAccepted
E215Disorder of parathyroid gland, unspecifiedNoneCannot group
E220Acromegaly and pituitary gigantismIAccepted
E221HyperprolactinemiaIAccepted
E222Syndrome of inappropriate secretion of antidiuretic hormoneIAccepted
E228Other hyperfunction of pituitary glandIAccepted
E229Hyperfunction of pituitary gland, unspecifiedNoneCannot group
E230HypopituitarismIAccepted
E231Drug-induced hypopituitarismIAccepted
E232Diabetes insipidusNoneCannot group
E233Hypothalamic dysfunction, not elsewhere classifiedIAccepted
E236Other disorders of pituitary glandIAccepted
E237Disorder of pituitary gland, unspecifiedNoneCannot group
E240Pituitary-dependent Cushing's diseaseIAccepted
E241Nelson's syndromeIAccepted
E242Drug-induced Cushing's syndromeIAccepted
E243Ectopic ACTH syndromeIAccepted
E244Alcohol-induced pseudo-Cushing's syndromeIAccepted
E248Other Cushing's syndromeIAccepted
E249Cushing's syndrome, unspecifiedIAccepted
E250Congenital adrenogenital disorders assoc w enzyme deficiencyIAccepted
E258Other adrenogenital disordersIAccepted
E259Adrenogenital disorder, unspecifiedNoneCannot group
E2601Conn's syndromeIAccepted
E2602Glucocorticoid-remediable aldosteronismIAccepted
E2609Other primary hyperaldosteronismIAccepted
E261Secondary hyperaldosteronismIAccepted
E2681Bartter's syndromeIAccepted
E2689Other hyperaldosteronismIAccepted
E269Hyperaldosteronism, unspecifiedNoneCannot group
E270Other adrenocortical overactivityIAccepted
E271Primary adrenocortical insufficiencyIAccepted
E272Addisonian crisisIAccepted
E273Drug-induced adrenocortical insufficiencyIAccepted
E2740Unspecified adrenocortical insufficiencyNoneCannot group
E2749Other adrenocortical insufficiencyNoneCannot group
E275Adrenomedullary hyperfunctionIAccepted
E278Other specified disorders of adrenal glandIAccepted
E279Disorder of adrenal gland, unspecifiedNoneCannot group
E280Estrogen excessAAccepted
E281Androgen excessAAccepted
E282Polycystic ovarian syndromeIAccepted
E28310Symptomatic premature menopauseAAccepted
E28319Asymptomatic premature menopauseAAccepted
E2839Other primary ovarian failureAAccepted
E288Other ovarian dysfunctionIAccepted
E289Ovarian dysfunction, unspecifiedNoneCannot group
E290Testicular hyperfunctionAAccepted
E291Testicular hypofunctionIAccepted
E298Other testicular dysfunctionIAccepted
E299Testicular dysfunction, unspecifiedNoneCannot group
E300Delayed pubertyNoneCannot group
E301Precocious pubertyNoneCannot group
E308Other disorders of pubertyNoneCannot group
E309Disorder of puberty, unspecifiedNoneCannot group
E310Autoimmune polyglandular failureIAccepted
E311Polyglandular hyperfunctionAAccepted
E3120Multiple endocrine neoplasia [MEN] syndrome, unspecifiedIAccepted
E3121Multiple endocrine neoplasia [MEN] type IIAccepted
E3122Multiple endocrine neoplasia [MEN] type IIAIAccepted
E3123Multiple endocrine neoplasia [MEN] type IIBAAccepted
E318Other polyglandular dysfunctionAAccepted
E319Polyglandular dysfunction, unspecifiedIAccepted
E320Persistent hyperplasia of thymusNoneCannot group
E321Abscess of thymusAAccepted
E328Other diseases of thymusIAccepted
E329Disease of thymus, unspecifiedNoneCannot group
E3400Carcinoid syndrome, unspecifiedIAccepted
E3401Carcinoid heart syndromeIAccepted
E3409Other carcinoid syndromeIAccepted
E341Other hypersecretion of intestinal hormonesAAccepted
E342Ectopic hormone secretion, not elsewhere classifiedAAccepted
E3430Short stature due to endocrine disorder, unspecifiedIAccepted
E3431Constitutional short statureIAccepted
E34321Primary insulin-like growth factor-1 (IGF-1) deficiencyIAccepted
E34322Insulin-like growth factor-1 (IGF-1) resistanceIAccepted
E34328Other genetic causes of short statureIAccepted
E34329Unspecified genetic causes of short statureIAccepted
E3439Other short stature due to endocrine disorderIAccepted
E344Constitutional tall statureAAccepted
E3450Androgen insensitivity syndrome, unspecifiedNoneCannot group
E3451Complete androgen insensitivity syndromeIAccepted
E3452Partial androgen insensitivity syndromeAAccepted
E348Other specified endocrine disordersIAccepted
E349Endocrine disorder, unspecifiedNoneCannot group
E35Disorders of endocrine glands in diseases classd elswhrNoneCannot group

Source: CMS HH PPS Grouper Software v07.1.26, effective 2026-04-01. This is the crosswalk Medicare runs a claim through. Grouping also depends on admission source, timing, the OASIS functional items and the rest of the diagnosis list.

The monthly home health regs digest

What CMS changed, what's due next, and what to do about it — one email a month, no fluff.